Enzalutamide/Leuprolide +/- Abiraterone/Pred in Prostate

Clinical trial NCT02268175 · COMPLETED

Trial details

NCT number: NCT02268175
Sponsor: Dana-Farber Cancer Institute
Status: COMPLETED
Phase: Phase 2
Study type: INTERVENTIONAL

Prostate Adenocarcinoma Prostate Cancer High Risk Prostate Cancer

Start date: 2014-10-01
Primary completion: 2018-01-01
Enrollment: 75

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.